{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:58:40Z","timestamp":1791489520065,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10072-022-06001-2","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:05:04Z","timestamp":1646996704000},"page":"4405-4412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Brain magnetic resonance imaging and severity of neurological disease in Wilson\u2019s disease \u2014 the neuroradiological correlations"],"prefix":"10.1007","volume":"43","author":[{"given":"Barbara","family":"R\u0119dzia-Ogrodnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cz\u0142onkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bembenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Antos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kurkowska-Jastrz\u0119bska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Skowro\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Smoli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2670-9651","authenticated-orcid":false,"given":"Tomasz","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"6001_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association For The Study of The Liver","year":"2012","unstructured":"European Association For The Study of The Liver (2012) EASL clinical practice Guidelines: Wilson\u2019s disease. J Hepatol 56:671\u2013685","journal-title":"J Hepatol"},{"key":"6001_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky ML, Cox D, Berr F (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139\u2013142","journal-title":"Liver Int"},{"key":"6001_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12883-018-1039-y","volume":"18","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska A, Litwin T, Dziezyc K, Karlinski M, Bring J, Bjartmar C (2018) Characteristic of newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson\u2019s Disease Rating Scale. BMC Neurol 18:34","journal-title":"BMC Neurol"},{"key":"6001_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML (2018) Wilson disease. Nat Rev Dis Primers 4:21","journal-title":"Nat Rev Dis Primers"},{"key":"6001_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1478-3231.2010.02354.x","volume":"31","author":"R Bruha","year":"2011","unstructured":"Bruha R, Marecek Z, Pospisilova L, Nevsimalova S, Vitek L, Martasek P, Nevoral J, Petrtyl J, Urbanek P, Jiraskova A, Ferenci P (2011) Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver Int 31:83\u201391","journal-title":"Liver Int"},{"key":"6001_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cgh.2013.09.025","volume":"12","author":"S Beinhardt","year":"2014","unstructured":"Beinhardt S, Leiss W, Stattermayer AF, Graziadei I, Zoller H, Stauber R, Maieron A, Datz C, Steindl-Munda P, Hofer H, Vogel W, Trauner M, Ferenci P (2014) Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol 12:683\u2013689","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6001_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-0-444-63625-6.00015-X","volume":"142","author":"A Czlonkowska","year":"2017","unstructured":"Czlonkowska A, Litwin T (2017) Wilson disease \u2013 currently used anticopper therapy. Handb Clin Neurol 142:181\u2013191","journal-title":"Handb Clin Neurol"},{"key":"6001_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/nyas.12437","volume":"1315","author":"KH Weiss","year":"2014","unstructured":"Weiss KH, Stremmel W (2014) Clinical considerations for an effective medical therapy in Wilson\u2019s disease. Ann N Y Acad Sci 1315:81\u201385","journal-title":"Ann N Y Acad Sci"},{"key":"6001_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/B978-0-444-63625-6.00018-5","volume":"142","author":"T Litwin","year":"2017","unstructured":"Litwin T, Dusek P, Czlonkowska A (2017) Symptomatic treatment of neurologic symptoms in Wilson disease. Handb Clin Neurol 142:211\u2013223","journal-title":"Handb Clin Neurol"},{"key":"6001_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2015.06.010","volume":"355","author":"T Litwin","year":"2015","unstructured":"Litwin T, Dzie\u017cyc K, Karli\u0144ski M, Chabik G, Czepiel W, Czlonkowska A (2015) Early neurological worsening in patients with Wilson\u2019s disease. J Neurol Sci 355:162\u2013167","journal-title":"J Neurol Sci"},{"key":"6001_CR11","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.21037\/atm.2018.12.09","volume":"7","author":"T Litwin","year":"2019","unstructured":"Litwin T, Dzie\u017cyc K, Czlonkowska A (2019) Wilson disease \u2013 treatment perspectives. Ann Transl Med 7:S68","journal-title":"Ann Transl Med"},{"key":"6001_CR12","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.21037\/atm.2019.03.02","volume":"7","author":"F Woimant","year":"2019","unstructured":"Woimant F, Djebrani-Oussedik N, Poujois A (2019) New tools for Wilson\u2019s disease diagnosis: exchangeable copper fraction. Ann Transl Med 7:S70","journal-title":"Ann Transl Med"},{"key":"6001_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.33176\/AACB-18-00014","volume":"40","author":"I Mohr","year":"2019","unstructured":"Mohr I, Weiss KH (2019) Biochemical markers for the diagnosis and monitoring of Wilson disease. Clin Biochem Rev 40:59\u201377","journal-title":"Clin Biochem Rev"},{"issue":"2007","key":"6001_CR14","first-page":"1","volume":"41","author":"A Cz\u0142onkowska","year":"2007","unstructured":"Cz\u0142onkowska A, Tarnacka B, Moller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH (2007) Unified Wilson\u2019s Disease Rating Scale \u2013 proposal for the neurological scoring of Wilson\u2019s disease patients. Neurol Neurochir Pol 41(2007):1\u201312","journal-title":"Neurol Neurochir Pol"},{"key":"6001_CR15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/mds.28018","volume":"35","author":"P Dusek","year":"2020","unstructured":"Dusek P, Smolinski L, Redzia-Ogrodnik B, Golebiowski M, Skowronska M, Poujois A, Laurencin C, Jastrzebska-Kurkowska I, Litwin T, Cz\u0142onkowska A (2020) Semiquantitative scale for assessing brain MRI abnormalities in Wilson disease: a validation study. Mov Disord 35:994\u20131001","journal-title":"Mov Disord"},{"key":"6001_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11011-013-9378-2","volume":"28","author":"T Litwin","year":"2013","unstructured":"Litwin T, Gromadzka G, Cz\u0142onkowska A, Go\u0142\u0119biowski M, Poniatowska R (2013) The effect of gender on brain MRI pathology in Wilson\u2019s disease. Metab Brain Dis 28:69\u201375","journal-title":"Metab Brain Dis"},{"key":"6001_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF00588068","volume":"36","author":"AC Magalhaes","year":"1994","unstructured":"Magalhaes AC, Caramelli P, Menezes JR, Lo LS, Bacheshi LA, Barbosa ER, Rosemberg LA, Magalhaes A (1994) Wilson\u2019s disease: MRI with clinical correlation. Neuroradiology 36:97\u2013100","journal-title":"Neuroradiology"},{"key":"6001_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF00589114","volume":"32","author":"L Prayer","year":"1990","unstructured":"Prayer L, Wimberger D, Kramer J, Grimm G, Oder W, Imhof H (1990) Cranial MRI in Wilson\u2019s disease. Neuroradiology 32:211\u2013214","journal-title":"Neuroradiology"},{"key":"6001_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1259\/bjr\/48911350","volume":"80","author":"S Sinha","year":"2007","unstructured":"Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK (2007) Sequential MRI changes in Wilson\u2019s disease with de-coppering therapy: a study of 50 patients. Br J Radiol 80:744\u2013749","journal-title":"Br J Radiol"},{"key":"6001_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1468-1331.2003.00661.x","volume":"10","author":"D Kozic","year":"2003","unstructured":"Kozic D, Svetel M, Petrovic B, Dragasevic N, Semnic R, Kostic VS (2003) MR imaging of the brain in patients with hepatic form of Wilson\u2019s disease. Eur J Neurol 10:587\u2013592","journal-title":"Eur J Neurol"},{"key":"6001_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jnnp.54.7.624","volume":"54","author":"S Hitoshi","year":"1991","unstructured":"Hitoshi S, Iwata M, Yoshikawa K (1991) Mid-brain pathology of Wilson\u2019s disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry 54:624\u2013626","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6001_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1259\/bjr.72.860.10624340","volume":"72","author":"A Alanen","year":"1999","unstructured":"Alanen A, Komu M, Pentinen M, Leino R (1999) Magnetic resonance imaging and proton MR spectroscopy in Wilson\u2019s disease. Brit J Radiol 72:749\u2013756","journal-title":"Brit J Radiol"},{"key":"6001_CR23","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/mds.21136","volume":"21","author":"M Sudmeyer","year":"2006","unstructured":"Sudmeyer M, Saleh A, Wojtecki L, Cohnen M, Gross J, Ploner M, Hefter H, Timmermann L, Schnitlzer A (2006) Wilson\u2019s disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures. Mov Disord 21:2134\u20132139","journal-title":"Mov Disord"},{"key":"6001_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0404.1989.tb03705.x","volume":"79","author":"R Midgard","year":"1989","unstructured":"Midgard R, Aarli JA, Julsrud OJ, Odegaard H (1989) Symptomatic hemidystonia of delayed onset. Magnetic resonance demonstration of pathology in the putamen and the caudate nucleus. Acta Neurol Scand 79:27\u201331","journal-title":"Acta Neurol Scand"},{"key":"6001_CR25","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2214\/ajr.167.6.8956601","volume":"167","author":"AD King","year":"1996","unstructured":"King AD, Walshe JM, Kendall BE, Chinn RJ, Paley MN, Wilkinson D, Halligan S, Hall-Craggs MA (1996) Cranial MR imaging in Wilson\u2019s disease. AJR Am J Roentgenol 167:1579\u20131584","journal-title":"AJR Am J Roentgenol"},{"key":"6001_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00234-009-0536-5","volume":"51","author":"M Da Costa","year":"2009","unstructured":"Da Costa M, Spitz M, Baschesi LA, Leite CC, Tavares L, Barbosa ER (2009) Wilson\u2019s disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology 51:627\u2013633","journal-title":"Neuroradiology"},{"key":"6001_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1212\/WNL.0b013e3182a95883","volume":"81","author":"JM Trocello","year":"2013","unstructured":"Trocello JM, Woimant F, El Balkhi S, Guichard JP, Poupon J, Chappuis P, Feillet F (2013) Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease. Neurology 81:1557","journal-title":"Neurology"},{"key":"6001_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1471-2377-13-127","volume":"13","author":"YE Kim","year":"2013","unstructured":"Kim YE, Yun JY, Yang HJ, Kim BS, Jeon BS (2013) Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson\u2019s disease. BMC Neurol 13:127","journal-title":"BMC Neurol"},{"key":"6001_CR29","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1007\/s12035-021-02525-4","volume":"58","author":"J Kalita","year":"2021","unstructured":"Kalita J, Kumar V, Parashar V, Misra UK (2021) Neuropsychiatric manifestations of Wilson disease: correlation with MRI and glutamate excitotoxicity. Mol Neurobiol 58:6020\u20136031","journal-title":"Mol Neurobiol"},{"key":"6001_CR30","doi-asserted-by":"publisher","unstructured":"Ziemssen T, Akgun K, Czlonkowska A, Bembenek J, Antos A, Przyby\u0142kowski A, Skowro\u0144ska M, Kurkowska-Jastrz\u0119bska I, Smoli\u0144ski L, Litwin T, (2022) Serum neurofilament light chain as a biomarker of brain injury in Wilson\u2019s disease: clinical and neuroradiological correlations. Mov Disord 2022.\u00a0https:\/\/doi.org\/10.1002\/mds.28946","DOI":"10.1002\/mds.28946"},{"key":"6001_CR31","first-page":"869","volume":"2","author":"KH Weiss","year":"2017","unstructured":"Weiss KH, Askari FK, Czlonkowska A, Ferenci P, Bronstein JM, Bega D, Ala A, Nicholl D, Flint S, Olsson L, Piltz T, Bjartmar C, Schilsky ML (2017) Bis-choline tetrathiomolybdate in patients with Wilson\u2019s disease: an open-label, multicentre, phase 2 study, Lancet Gastroenterol. Hepatol 2:869\u2013876","journal-title":"Hepatol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06001-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T04:08:28Z","timestamp":1655784508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06001-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6001"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06001-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"11 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Bioethical Committee of the Institute of Psychiatry and Neurology, Warsaw, Poland.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}